Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio

Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.

Oxygen
• Source: shutterstock.com

Philips Healthcare has acquired Xhale Assurance Inc. to add a novel pulse oximetry technology to complement its patient monitoring portfolio, which already offers the marketing-leading Rainbow SET pulse oximetry products from Masimo Corp.

Philips announced Aug. 29 that it bought Florida-based Xhale, developer of the SpO2 sensor, for an undisclosed sum. Xhale was founded in 2005 to develop the underlying sensor technology licensed...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

More from Business